Russian Lab Unveils Cancer Vaccine Release Target – altnews.org
4 Articles
4 Articles
The medical world could be at the forefront of unprecedented progress: a personalized cancer vaccine will soon begin to be applied in melanoma patients, as announced by the director of the National Center for Epidemiology and Microbiology Research Gamaleya, Alexánder Guíntsburg. Unlike conventional vaccines, this new formula is designed individually, based on the genetic profile of each patient. Thanks to the use of neoantigen-based technology, …
The first patients could start treatment with a Russian vaccine adapted for cancer in the coming months, said Alexánder Guíntsburg, who heads the National Center for Epidemiology and Microbiology Research Gamaleya. Alexánder Guíntsburg, a scientist and director of the laboratory, said in a statement, according to RIA Novosti: “According to the current plan, agreed with [...]
Russian lab unveils cancer vaccine release target
Personalized treatment could begin “within months,” according to the Gamaleya Center’s directorFILE PHOTO © Sputnik / Alexey NikolskiyRussia’s first patients could begin receiving a newly developed cancer vaccine within the next few months, Alexander Gintsburg, director of the Gamaleya Research Institute of Epidemiology and Microbiology, has announced. The breakthrough drug is a personalized, AI-assisted, mRNA-based vaccine designed to target m…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium